How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Genomics Blockchain Market
- By Blockchain Type: Public Blockchain, Private Blockchain, Consortium Blockchain, Hybrid Blockchain
- By Application: Genomic Data Storage and Sharing, Genomic Data Security and Privacy, Genomic Data Marketplace, Clinical Trial Data Management, Personalized Medicine
- By End User: Pharmaceutical and Biotechnology Companies, Healthcare Providers, Research Institutions, Genomic Data Consumers, Government and Regulatory Bodies
- By Service Model: Platform as a Service (PaaS), Software as a Service (SaaS), Infrastructure as a Service (IaaS)
- By Technology Component: Smart Contracts, Cryptographic Security, Distributed Ledger Technology, Data Tokenization
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Public Blockchain leads By Blockchain Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 11 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 286 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.179 →
- 12 Company Profiles 11 players: SWOT & benchmarking p.187 →
Full report · locked preview
Everything inside the Genomics Blockchain Market report
A complete, evidence-based study - 12 chapters and 120 sections covering market size, segmentation across 5 axes, regional analysis and 11 company profiles, forecast to 2033.
Segmentation covered
Blockchain Type 4
Application 5
End User 5
Service Model 3
Technology Component 4
Companies profiled
Nebula Genomics
EncrypGen
Genobank.io
Shivom
LunaDNA
GeneChain
Zenome
Gene-Chain
DNAtix
Gene Nexus
Lifebit
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
11 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Nebula Genomics
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →EncrypGen
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Genobank.io
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Shivom
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →LunaDNA
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →GeneChain
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →Zenome
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Gene-Chain
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →DNAtix
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Gene Nexus
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.209 →Lifebit
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.214 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$4,861M by 2033 · 6.7% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Public Blockchain44.9
- Private Blockchain21.1
- Consortium Blockchain19.7
- Hybrid Blockchain14.3
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$954.0M → $1,778M · 8.1%
Europe$664.9M → $1,206M · 7.7%
Asia Pacific$607.1M → $1,012M · 6.6%
Latin America$375.8M → $689.3M · 7.9%
Middle East and Africa$289.1M → $479.9M · 6.5%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →6.662026
6.682027
6.692028
6.702029
6.702030
6.732031
6.742032
6.752033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Nebula Genomics11.3
- EncrypGen13.6
- Genobank.io12.9
- Shivom12.4
- LunaDNA11.6
- GeneChain10.3
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Blockchain Type14.5%
Application26.9%
End User29.6%
Service Model18.9%
Technology Component10.1%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.4
- Europe23.4
- Asia Pacific19.6
- Latin America13.3
- Middle East and Africa9.3
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Nebula Genomics | 83 | 91 | 88 | 84 | 87 | 73 | 84 |
| EncrypGen | 78 | 86 | 70 | 93 | 80 | 79 | 81 |
| Genobank.io | 69 | 69 | 77 | 70 | 84 | 70 | 73 |
| Shivom | 71 | 71 | 61 | 61 | 63 | 75 | 67 |
| LunaDNA | 72 | 69 | 76 | 76 | 53 | 71 | 70 |
| GeneChain | 56 | 58 | 65 | 63 | 60 | 69 | 62 |
| Zenome | 63 | 45 | 64 | 60 | 61 | 51 | 57 |
| Gene-Chain | 56 | 56 | 58 | 39 | 37 | 38 | 47 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Nebula Genomics
- EncrypGen
- Genobank.io
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Nebula Genomics | ◐ | ✓ | ✓ | ✓ | ✓ | ◐ |
| EncrypGen | ✓ | ✓ | ◐ | ✓ | ✓ | ✓ |
| Genobank.io | ◐ | − | ✓ | ◐ | ✓ | ◐ |
| Shivom | ◐ | ◐ | ◐ | ◐ | ✓ | ✓ |
| LunaDNA | ✓ | ◐ | ◐ | ✓ | − | − |
| GeneChain | ◐ | ◐ | − | ◐ | ◐ | − |
| Zenome | ◐ | − | ✓ | − | − | − |
| Gene-Chain | ◐ | ◐ | ◐ | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Nebula Genomics84
2EncrypGen81
3Genobank.io73
4LunaDNA70
5Shivom67
6GeneChain62
7Zenome57
8Gene-Chain47
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Nebula GenomicsEncrypGen
Challenger3
Strong scale, closing on the leaders.
Genobank.ioShivomLunaDNA
Contender2
Focused players with pockets of strength.
GeneChainZenome
Niche1
Specialists in a single segment or region.
Gene-Chain
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Blockchain Type in North America, then scale across Genomics Blockchain Market — a $265M beachhead inside a $4.77B market.
Beachhead (SOM)$265Mobtainable near-term
Serviceable (SAM)$1.62Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Public Blockchain
Best fit — highest urgency & budget in Blockchain Type.
Economic buyer79 fit
Private Blockchain
Strong fit — clear ROI and a fast path to value.
End user67 fit
Consortium Blockchain
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Blockchain Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales47%
Partner / channel26%
Digital / self-serve21%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Blockchain Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Genomics Blockchain Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified41%
Sales qualified20%
Evaluation12%
Closed-won7%
$13.0KCAC
$74KLTV
5.7:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Genomics Blockchain Market is a high-growth opportunity — $11.1B by 2033, compounding at 10.4%.
TAM · 2025$5.01Btoday
TAM · 2033$11.1Bforecast
CAGR10.4%2027–2033
Cumulative$69.2Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$11.1BTotal addressable market
SAM$4.25BServiceable available market
SOM$906MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →10.4% CAGR
Demand compounds through 2033, outpacing GDP across Blockchain Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Blockchain Type moving from early to mainstream — durable secular demand.
Consolidation upside
11+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$11.1BLarge & growingTAM by 2033 at 10.4% CAGR
$4.25BServiceable nowreachable with today’s model
$906MBeachhead winobtainable near-term share
11+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$8.63BBear6.8% CAGR
$11.1BBase10.4% CAGR
$14.2BBull13.8% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Genomics Blockchain Market — a $5.81B market by 2033. Plan: grow share from 9.2% to 15.5%.
Market size · 2033$5.81Btotal addressable
Market CAGR3.4%2027–2033
Target share15.5%from 9.2% today
Revenue ambition$901Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.2% | 15.5% | On track |
| Revenue | $566M | $901M | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 34.9% | 39.1% | Ahead |
| Customer retention | 90.0% | 96.7% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Blockchain Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Blockchain Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $108M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Blockchain Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossAhead
- Input-cost & supply riskOn track
- Regulatory / policy changeBehind
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Genomics Blockchain Market conversation — a $2.59B market you can size, segment and defend in minutes.
Market size · 2033$2.59Btotal opportunity
Growth8.3%CAGR to 2033
Addressable buyers1,685+accounts in scope
Typical ROI5.7×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Blockchain Type
Goal Grow share in Blockchain Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.7×return on cost, year one
< 2 mopayback period
$42K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
11+players profiled in this market
Coverage includes
Nebula GenomicsEncrypGenGenobank.ioShivomLunaDNAGeneChainZenomeGene-Chain+3 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Genomics Blockchain Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Genomics Blockchain Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Genomic DNA Extraction Kit Market
Market size, share, segmentation and regional forecast.
$755M market · 2025 base year
View reportGenomic Data Analysis Service Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportGenomic Data Analysis and Interpretation Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportGenomic Cancer Testing Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportGenomic and Proteomic Tool Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportGenome Sequencing Service Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportGenome Perturbation Tools Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportGenome Engineering Editing Market
Market size, share, segmentation and regional forecast.
$986M market · 2025 base year
View reportGenome Editing Techniques Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportGenome Editing Services Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportGenome Editing and Genome Engineering Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportGenome (DNA) Sequencing Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.